期刊文献+

133例心脏移植供心保护回顾分析 被引量:8

Management of donor heart protection in orthotopic heart transplantation( a report of 133 cases)
下载PDF
导出
摘要 目的总结133例心脏移植的供心获取及其保护经验并做回顾分析。方法武汉协和医院心脏外科2008年9月至2014年5月共完成133例原位心脏移植,其中非停搏供心103例,停搏供心30例。非停搏供心经主动脉根部灌注4℃改良St.Thomas液,供心快速停搏,取下供心后再灌注8℃康斯特保护液(HTK液)并置于HTK液中低温浸泡保存。停搏供心经主动脉根部灌注8℃HTK液,取下供心后再灌注HTK液并置于HTK液中保存。在供心修剪时均经主动脉根部再次灌注HTK液。结果非停搏供心组,92例供心自动复跳,11例电除颤复跳;热缺血时间(3.25±2.25)min,冷缺血时间(253.22±136.73)min,术后主动脉内球囊反搏(IABP)使用率9.5%,术后三周左室射血分数(LVEF)值(65.52±6.72)%,术后一年生存率92.55%。停搏供心组,23例供心自动复跳,7例电除颤复跳。热缺血时间(5.78±2.82)min,冷缺血时间(179.12±52.43)min,术后IABP使用率10.1%,术后三周LVEF值(65.78±7.22)%,术后一年生存率91.07%。结论本中心对两类供心采用不同获取及保护方法均确切有效,扩大了边缘供心的使用范围,提高了手术疗效。 Objective To summarize the management experiences of donor heart protection in 133 orthotopic heart transplantation patients. Methods From Sep. 2008 to May 2014, 133 patients with end-stage heart disease underwent orthotopic heart transplantation in Wuhan Union hospital. Among them, 103 cases received non-arrest donor heart ( groupⅠ) and 30 cases received arrest donor heart ( groupⅡ) . In Group I, 4℃ ST. Thomas solution was infused through aortic roots after aorta was cross clamped to make donor hearts arrested quickly first, then the donor hearts were soaked and preserved and transported in 8℃ HTK solution;In groupⅡ, 8℃HTK solution was infused through aortic roots after aorta was cross clamped, and the donor hearts were preserved in HTK solution. Results In group I, 92 patients recovered heart beating automatically after clamp removed, and 11 patients recovered heart beating by electric defibrillation. The donor heart warm ischemic period was (3.25±2.25) min and cold ischemic period was (253.22±136.73) min. Postoperative utilization rate of IABP was 9.5%, EF values of three weeks after heart transplantation was (65.52 ± 6.72)%, one year survival rate was 92.55%. In group II, 23 cases recovered heart beating automatically after clamp removed and 7 patients recovered heart beating by electric defibrillation. The donor heart warm ischemic period was ( 5. 78 ± 2. 82) min and cold ischemic period was (179.12±52.43) min. Postoperative utilization rate of IABP was 10.1%, EF values of three weeks after heart transplantation was (65.78±7.22), one year survival rate was 91.07%. Conclusion Using different donor heart procurement and efficient heart preservation during perioperative period are considerably important for a successful heart transplantion, it expand the use of edging donor hearts and improve the success rate of heart transplantation.
出处 《中国体外循环杂志》 2014年第4期219-221,244,共4页 Chinese Journal of Extracorporeal Circulation
关键词 心脏移植 供心保护 器官保存液 Heart transplantation Donor heart protection Organ preservation solution
  • 相关文献

参考文献11

  • 1Nunez JR, Del Rio F, Lepez E, et al. Non-heart-beating do- nors: An excellent choice to increase the donor pool [ J ]. Trans- plant Proc, 2005, 37(9) :3651-3654.
  • 2Singhal AK, Abrams JD, Mohara J, et al. Potential suitability for transplantation of hearts from human non - heart-beating donors: data review from the gift of life donor program [ J ]. J Heart Lung Transplant, 2005, 24 ( 10 ) : 1657 - 1664.
  • 3Lee KC, Chang CY, Chuang YC, et al. Combined St. Thomas and histidine- tryptophan- ketoglutarat solutions for myocardial preservation in heart transplantation patients [ J]. Transplant Proc, 2012, 44(4) :886-889.
  • 4Careaga G, Salazar D, T611ez S, et al. Clinical impact of histi- dine-ketoglutarate-tryptophan(HTK) cardioplegic solution on the perioperative period in open heart surgery patients [ J]. Arch Med Res, 2001,32(4) :296-299.
  • 5Ohkado A, Can-Danh H, Sommers KE, et al. Evaluation of high- ly buffered low-calcium solution for long-term preservationof the heart. Comparison with University of Wisconsin solution [ J ]. J Thorac Cardiovasc Stag, 1994,108(4) :762-771.
  • 6Banner NR, Thomas HL, Cumow E, et al. The importance of cold and warm cardiac isehemia for survival after heart transplan- tation [ J ]. Transplantation, 2008, 86 (4) : 542-547.
  • 7Lu H, Hachida M, Ohkado A, et al. Cardioprotective efficacy of ischemic preconditioning on long-term myocardial ischemia [ J]. Int J Cardiol, 1997, 62 Suppl 1 :S49-54.
  • 8Wei J, Chang CY, Chuang YC, et al. Successful heart transplan- tation after 13 hours of donor heart ischemia with the use of HTK solution : a case report [ J ]. Transplant Proc, 2005, 37 (5) :2253 -2254.
  • 9Fernandez J, Aranda J, Mabbot D, et al. Overseas procurementof donor hearts: ischemic time effect on postoperative outcomes [J] .Transplant Proe, 2001,33(7-8) :3803-3804.
  • 10Bfiganti EM, Bergin PJ, Rosenfeldt FL, et al. Successful long- term outcome with pyolonged ischemic time cardiac allografts[ J]. J Heart Lung Transplant, 1995,14 (5) : 840- 845.

同被引文献48

引证文献8

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部